Peijia Medical Limited
9996.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.1B
Close$
Share Statistics
| Market cap | $3.10 Billion |
|---|---|
| Enterprise Value | $2.94 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.31 |
| Beta | 0.62 |
| Outstanding Shares | 670,283,000 |
Return
| Return on Equity | -19.90% |
|---|---|
| Return on Assets | -12.57% |
| Return on Invested Capital | -13.86% |
Valuation & Multiples
| P/E Ratio | -18.65 |
|---|---|
| PEG | 20.93 |
| Price to Sales | 2.2 |
| Price to Book Ratio | 2.2 |
| Enterprise Value to Revenue | 2.03 |
| Enterprise Value to EBIT | -9.66 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.22 |
| Debt to Equity | 0.36 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 20, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$490.30 M
Average shareholder expectationNext Earnings Call
Expected Date
April 1, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$607.92 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Peijia Medical Limited
1,033 employees
CEO: Yi Zhang Peijia Medical Limited specializes in the innovation and development of advanced medical devices for transcatheter valve therapies and neurointerventional procedures. Their extensive portfolio of transcatheter valve solutions includes nu...